Purapharm International Hk
Purapharm International HK, a leading player in the herbal medicine industry, is headquartered in Hong Kong and operates extensively across Asia and beyond. Founded in 1998, the company has established itself as a pioneer in the development and distribution of traditional Chinese medicine (TCM) products, focusing on quality and innovation. Purapharm's core offerings include a diverse range of herbal formulations and health supplements, distinguished by their commitment to scientific research and sustainable sourcing. The company has achieved notable milestones, including the introduction of advanced manufacturing processes that ensure product efficacy and safety. With a strong market position, Purapharm International HK is recognised for its contributions to the TCM sector, earning accolades for its dedication to promoting holistic health solutions. The company continues to expand its reach, making significant strides in both local and international markets.
DitchCarbon Score
How does Purapharm International Hk's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Purapharm International Hk's score of 12 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Purapharm International Hk's reported carbon emissions
In 2023, Purapharm International HK reported total carbon emissions of approximately 12,829,000 kg CO2e. This figure includes 4,205,000 kg CO2e from Scope 1 emissions and 8,624,000 kg CO2e from Scope 2 emissions. Notably, there were no reported Scope 3 emissions for this year. The previous year, 2022, saw total emissions of about 12,974,000 kg CO2e, with Scope 1 emissions at 4,471,000 kg CO2e and Scope 2 emissions at 8,503,000 kg CO2e. This indicates a slight reduction in total emissions from 2022 to 2023. Over the years, Purapharm's emissions have fluctuated, with a peak in 2019 at approximately 13,652,000 kg CO2e. The company has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or any formal climate pledges, suggesting a need for clearer commitments in addressing climate change. Overall, while Purapharm International HK has made some progress in managing its carbon footprint, the absence of defined reduction targets highlights an opportunity for the company to enhance its climate strategy and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 3,630,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 4,606,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | 00,000,000 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Purapharm International Hk is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
